On October 16, 2025, Rani Therapeutics Holdings, Inc. announced a securities purchase agreement for a private placement of 42.63 million shares, raising approximately $60.3 million. This includes warrants to purchase additional shares and involves partnerships with institutional investors and board member Mir Imran.